Stay updated on Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Sign up to get notified when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.

Latest updates to the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter Revision text updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check17 days agoChange DetectedPulmonary fibrosis was added as a related topic on the page. A new Resources entry linking to the Genetic and Rare Diseases Information Center was included.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2. No visible content changes were made to the study details.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision note updated from v3.4.0 to v3.4.1. There are no changes to the study details, eligibility criteria, or results displayed on this page.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page shows a revision label update from v3.4.0 to v3.4.1. The new label appears as 'Revision: v3.4.1' and the old label 'Revision: v3.4.0' is removed.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.